Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
assigned, bought, cisplatin, confirmatory, constitutionality, correctly, defrauded, description, Donor, doublet, False, falsifying, frequency, gemcitabine, herd, IRA, ladiratuzumab, misrepresented, moot, neoantigen, percentage, platinum, PRIME, prosecution, proxy, PTE, repay, resubmission, satisfy, signaling, sued, swine, Taiwan, TCJA, tentatively, tract, unsealed, unvested, verification, view, violative, withdrawn, withdrew
Removed:
added, advance, applied, arm, assert, Australia, authorize, Bristol, buying, calculated, certified, chain, challenged, computation, consistent, deadline, demonstrate, discontinuation, disruption, docetaxel, endpoint, enzalutamide, experiencing, expert, formulation, free, futility, goodwill, IIB, IIC, independent, indirectly, instituted, inter, intervene, IPR, LEAP, macroeconomic, modified, notional, patient, performing, petition, placebo, plaintiff, pretrial, prospectively, radiographic, recurrence, remanded, remeasurement, rendered, renewed, setting, significance, statistical, studying, submitting, supplemental, Supreme, survival, transferring, unnamed, USPTO, vacated, voted
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view